Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Posterior Capsule Opacification clinical trials
2 of 2 indexed Posterior Capsule Opacification trials are currently recruiting.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Posterior Capsule Opacification: 2 US clinical trials tracked, 2 recruiting.
Posterior Capsule Opacification is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. The most active sponsor is Dr. Daniel H. Chang, MD, running 1 of these trials.
Enrollment posture brief
Registry condition posterior-capsule-opacification
OPEN 2 | RECR 100% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Posterior Capsule Opacification lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Posterior Capsule Opacification on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Posterior Capsule Opacification is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
IC-8 Apthera IOL New Enrollment Post Approval Study
Bausch & Lomb Incorporated
NCT06060041
Clinical Evaluation of Low Contrast Visual Performance and Low Light Phenomena in Patients With Various Intraocular Lens Implants
Dr. Daniel H. Chang, MD
NCT07213167
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Posterior Capsule Opacification records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Posterior Capsule Opacification trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Posterior Capsule Opacification page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Posterior Capsule Opacification trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dr. Daniel H. Chang, MD sponsors the most Posterior Capsule Opacification trials on record, review their full trial history before evaluating a specific study. See Dr. Daniel H. Chang, MD's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Posterior Capsule Opacification condition card totals 2 registered trials; most-linked intervention None-placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.